Seres Therapeutics MCRB
NASDAQ MCRB
$2.09 -0.04 (-1.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) Price to FCF (2016 - 2025)

Updated

Seres Therapeutics' Price to FCF came in at 164.39 for Q4 2025.

Analysis

Seres Therapeutics (MCRB) Price to FCF (2016 - 2025) Analysis & Trends

Going back to Q1 2016, Seres Therapeutics' Price to FCF data covers 6 quarters.

  • The Q4 2025 figure represents the lowest quarterly Price to FCF since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Seres Therapeutics 20.29 Mn -118.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 164.39
Sep 30, 2021 19.72
Dec 31, 2016 17.81
Sep 30, 2016 13.73
Jun 30, 2016 28.53
Mar 31, 2016 16.98
API Access

Seres Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=MCRB&period=max&api_key=YOUR_API_KEY